Feb20

Mayo Clinic CEO will retire at the end of 2018

Dr. John Noseworthy plans to retire from his post as president and CEO of Mayo Clinic at the end of 2018. The health system hopes to pin down a suitable successor by the early fall.

Feb20

Trump administration proposed rule to bring back short-term health insurance options could weaken ACA

The new rule is expected to entice younger and healthier people from the general insurance pool by allowing a range of lower-cost options that don’t include all the benefits required by the federal law — including plans that can reject people with…

Feb20

Wildflower Health app gives Wyoming families tools to track health, find resources

The Wyoming Department of Health has rolled out a new app that seeks to help patients track the health of each member of his or her family. The tool was developed by San Francisco-based Wildflower Health.

Feb20

Siemens Healthineers is preparing to file IPO

It’s not the first time the German medical imaging and diagnostic business has made its intentions to file an IPO known, but perhaps the company is betting on a more receptive audience in the current market.

Feb20

Google trains machine learning algorithm to use eyes to learn about the heart

If the eyes are the window to the soul, Google thinks it’s proven that images of the retina can offer a window on the state of the heart.

Feb19

Golden Financial Care takes home $25K as winner of Aging Startup Challenge

San Francisco-based Golden Financial Care, a startup that provides a tool to help adult children improve their parents’ financial health, was named the winner of the first Aging Startup Challenge in Minneapolis. The February 15 competition was c…

Feb17

6 healthcare priorities highlighted in FDA’s budget proposal

FDA Commissioner Scott Gottlieb offered a window into the regulator’s priorities for drug and device development as part of its budget proposal.

Feb16

How can the U.S. catch up on biosimilars?

Here’s what is preventing biosimilars, which are growing in importance, from being more widely available in the U.S.